TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 46 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2015. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $16,000 | -42.9% | 34,257 | -14.2% | 0.00% | – |
| Q3 2016 | $28,000 | -69.6% | 39,930 | -14.0% | 0.00% | – |
| Q2 2016 | $92,000 | 0.0% | 46,430 | +21.7% | 0.00% | – |
| Q1 2016 | $92,000 | -68.6% | 38,165 | 0.0% | 0.00% | – |
| Q4 2015 | $293,000 | +45.0% | 38,165 | 0.0% | 0.00% | – |
| Q3 2015 | $202,000 | +29.5% | 38,165 | +120.6% | 0.00% | – |
| Q2 2015 | $156,000 | +102.6% | 17,300 | +41.8% | 0.00% | – |
| Q1 2015 | $77,000 | – | 12,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|